Related Experiment Video
Updated: Apr 30, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.6K
Radiation therapy for Hodgkin lymphoma
Acta Cardiologica
|May 3, 2014
Summary
Long-term cardiac complications, including heart failure and coronary artery disease, are a significant risk for Hodgkin lymphoma survivors treated with radio(chemo)therapy. Cardiovascular event risk is 2-7 times higher, necessitating vigilant cardiac monitoring.
Area of Science:
- Cardiology
- Oncology
- Radiotherapy
Background:
- Radio(chemo)therapy is a standard treatment for Hodgkin lymphoma.
- Long-term survivors of Hodgkin lymphoma face significant health challenges.
- Cardiac complications are a known, serious side effect of chest irradiation.
Observation:
- Chest irradiation for Hodgkin lymphoma can lead to various long-term cardiac issues.
- These complications include coronary artery disease, arrhythmias, valvular disease, pericardial disease, cardiomyopathy, and heart failure.
- The severity of myocardial damage correlates with radiation dose, volume, and technique.
Findings:
- Patient age at treatment and pre-existing cardiac risk factors influence the extent of cardiac damage.
- The relative risk of cardiovascular events is elevated 2-fold to 7-fold compared to the general population.
- Clinical presentations range from asymptomatic conditions to end-stage coronary or valvular disease.
Implications:
- Survivors require lifelong cardiac surveillance to detect and manage potential complications early.
- Understanding dose-volume effects and patient-specific factors can help personalize treatment strategies.
- Further research into cardioprotective measures during radiotherapy is crucial for improving long-term outcomes.
